Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2020 2
2021 4
2022 4
2023 1
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients.
Ohuchi M, Yagishita S, Jo H, Akagi K, Inaba Higashiyama R, Masuda K, Shinno Y, Okuma Y, Yoshida T, Goto Y, Horinouchi H, Makino Y, Yamamoto N, Ohe Y, Hamada A. Ohuchi M, et al. Among authors: jo h. Lung Cancer. 2022 Nov;173:35-42. doi: 10.1016/j.lungcan.2022.08.018. Epub 2022 Sep 6. Lung Cancer. 2022. PMID: 36116168
Loxoprofen-induced interstitial pneumonia: a case report.
Kato M, Sasaki S, Sekimoto Y, Arano N, Jo H, Suina K, Kuriyama S, Muraki K, Nagashima O, Yoshioka Y, Tominaga S, Takahashi K. Kato M, et al. Among authors: jo h. J Med Case Rep. 2016 May 25;10(1):128. doi: 10.1186/s13256-016-0919-2. J Med Case Rep. 2016. PMID: 27225339 Free PMC article.
Clinical Characteristics and Pharmacokinetics Change of Long-Term Responders to Antiprogrammed Cell Death Protein 1 Inhibitor Among Patients With Advanced NSCLC.
Jo H, Yoshida T, Yagishita S, Ohuchi M, Matsumoto Y, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yamamoto N, Takahashi K, Motoi N, Hamada A, Ohe Y. Jo H, et al. JTO Clin Res Rep. 2023 Feb 11;4(4):100474. doi: 10.1016/j.jtocrr.2023.100474. eCollection 2023 Apr. JTO Clin Res Rep. 2023. PMID: 37007867 Free PMC article.
12 results